Clinical Practice Changes After Post-Market Safety Reports on Desmopressin Orally Disintegrating Tablet in Japan: A Single-Center Retrospective Study.

Yasuda, Takuma; Murakami, Takaaki; Yasoda, Akihiro; Sone, Masakatsu; Harada, Norio; Ogura, Masahito; Inagaki, Nobuya

Yasuda, Takuma; Murakami, Takaaki; Yasoda, Akihiro; Sone, Masakatsu; Harada, Norio; Ogura, Masahito; Inagaki, Nobuya.

Afiliação

Yasuda T; Department of Diabetes, Endocrinology and Nutrition, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Murakami T; The first two authors (T.Y. and T.M.) contributed equally to this work.
Yasoda A; Department of Diabetes, Endocrinology and Nutrition, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Sone M; The first two authors (T.Y. and T.M.) contributed equally to this work.
Harada N; Clinical Research Center, National Hospital Organization Kyoto Medical Center, Kyoto, Japan.
Ogura M; Department of Diabetes, Endocrinology and Nutrition, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Inagaki N; Division of Metabolism and Endocrinology, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan.

J Clin Med Res ; 13(2): 92-100, 2021 Feb.

Article em En | MEDLINE | ID: mdl-33747323